Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Measles vaccination policy

B G Williams1, F T Cutts, C Dye

  • 1Epidemiology Research Unit, Johannesburg, South Africa.

Epidemiology and Infection
|December 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retrospective analysis of the incidence and clinicopathological findings associated with ammonium urate urolithiasis in dogs with congenital portosystemic shunts: 363 cases (2010-2023).

The Journal of small animal practice·2025
Same author

Scale-free dynamics of COVID-19 in a Brazilian city.

Applied mathematical modelling·2023
Same author

Infective endocarditis.

BJA education·2023
Same author

Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.

Vaccine·2022
Same author

Computed tomographic findings in dogs with suspected aspiration pneumonia: 38 cases (2014-2019).

The Journal of small animal practice·2022
Same author

Advances in transcatheter aortic valve implantation, part 2: perioperative care.

BJA education·2021
Same journal

Epidemiological Investigation of a Large Trichinellosis Outbreak in Lebanon, October 2023 - February 2024.

Epidemiology and infection·2026
Same journal

Pandemic preparedness: potential of routine general practice data for infectious disease early signal detection.

Epidemiology and infection·2026
Same journal

ASSOCIATION BETWEEN INTRODUCTION OF 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE AND BURDEN OF HOSPITALIZED ADULT PNEUMOCOCCAL DISEASE IN TAIWAN - A RETROSPECTIVE DATABASE STUDY.

Epidemiology and infection·2026
Same journal

Using forensic autopsy data to estimate the age-specific infection fatality risk of COVID-19.

Epidemiology and infection·2026
Same journal

Maternal and congenital syphilis in Fiji 2019-2022: a secondary analysis of clinical trial data.

Epidemiology and infection·2026
Same journal

The Socio-economic Shield Limits Lassa Virus Spillover in Urban West Africa.

Epidemiology and infection·2026
See all related articles

Optimal measles vaccination age is 11-19 months, considering maternal antibody decline. Delaying vaccination is preferable to vaccinating too early to prevent future measles epidemics.

Area of Science:

  • Pediatrics
  • Epidemiology
  • Immunology

Background:

  • Measles elimination requires optimal vaccination policies to prevent future epidemics.
  • Maternal antibody presence impacts measles vaccine efficacy, necessitating age-specific vaccination strategies.
  • Current infant vaccination in developing countries may not be optimal due to high transmission rates.

Purpose of the Study:

  • To determine the optimal age for measles vaccination based on maternal antibody decline.
  • To evaluate the impact of vaccination timing on vaccine efficacy and epidemic prevention.
  • To explore the benefits of two-dose vaccination schedules.

Main Methods:

  • Quantitative reappraisal of maternal antibody decline and seroconversion rates by age.
  • Development of an analytical mathematical model incorporating antibody decline data.

Related Experiment Videos

  • Exploration of two-dose vaccination schedules concerning coverage and efficacy.
  • Main Results:

    • Maternal antibody decline follows delayed exponentials with half-lives of 1-2 months.
    • Optimal age for a single measles vaccine dose is 11-19 months, independent of coverage.
    • Late vaccination is preferable to early vaccination if the optimal window is missed.

    Conclusions:

    • Developing countries should consider switching from infant to second-year-of-life measles vaccination.
    • A single-dose strategy optimized for age is crucial for preventing measles epidemics.
    • Two-dose schedules offer benefits primarily for increasing net vaccine efficacy after maximizing single-dose coverage.